Hair thinning: PRP, exosomes and laser
Platelet-rich plasma · 'vampire' scalp treatment · low-level laser caps · exosome scalp therapy
Hair-loss treatment is a top health search; PRP and exosome scalp content has made clinic hair treatments mainstream.
Search interest: about 1,200 searches a month in Singapore for “hair loss treatment” (Ahrefs, October 2026).
Dr Sin Yong's H2LT and Luminescence protocols treat the follicular environment — a third route, separate from circulation and the androgen pathway.
Reviewed against the Aesthetics International standard. Category: Hair.
Does Hair thinning work?
Promising. Dr Sin Yong's H2LT and Luminescence protocols treat the follicular environment — a third route, separate from circulation and the androgen pathway. PRP has reasonable evidence for improving density in androgenetic alopecia, with variable protocols.
- Verdict
- Promising Plausible mechanism and early evidence. Reasonable to try with realistic expectations.
- Evidence base
- 4 PubMed-indexed studies cited below, including systematic reviews.
- Suits
- Early to moderate thinning with miniaturised but living follicles; people willing to maintain treatment.
- Not for
- Scarring alopecia, fully bald areas, anyone expecting a one-off cure. Relocating hair does not stop the loss that made the transplant necessary.
- In Singapore
- PRP is prepared and injected by doctors in Singapore clinics; laser caps are consumer or clinic devices.
- Category
- Hair · about 1,200 searches a month in Singapore for “hair loss treatment”
- Reviewed
- 1 October 2026 by Aesthetics International. Revised as evidence and regulation change.
What it is
Non-surgical options for thinning hair: PRP injections of the patient's own concentrated platelets into the scalp, low-level laser or LED caps, scalp microneedling with or without topicals, and newer exosome applications.
How it works
Hair loss has several causes and they behave differently; which one you have is the first question, not the last. PRP delivers growth factors to follicles still alive; laser light modestly extends the growth phase; microneedling improves topical delivery and may stimulate follicles directly. None regrows a dead follicle — the work is saving the ones still alive.
What the evidence says
PRP has reasonable evidence for improving density in androgenetic alopecia, with variable protocols. Low-level laser has consistent modest evidence. Microneedling adds to medical therapy. Exosomes are early and unregulated. All work alongside, not instead of, medical management prescribed by a doctor.
What people are saying
Paraphrased from public discussion on TikTok, Instagram, Reddit and in the press. Not testimonials, and not about any one clinic. Reported in: healthline.com, health.clevelandclinic.org.
What the studies show
- systematic review
Pooled randomised trials showed PRP increased hair density at three and six months versus placebo, with hair count and diameter gains not significantly different from placebo and no serious adverse events.
Platelet-Rich Plasma for Androgenetic Alopecia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. — J Cutan Med Surg, 2023. PMID 37533146.
- systematic review
Low-level laser therapy modestly improved hair density in androgenetic alopecia, with evidence for other alopecia types lacking.
Low-Level Laser and LED Therapy in Alopecia: A Systematic Review and Meta-Analysis. — Dermatol Surg, 2025. PMID 39404126.
- systematic review
Exosome hair studies were small, short and used non-standardised products; the authors described the evidence as preliminary.
Systematic review of exosome treatment in hair restoration: Preliminary evidence, safety, and future directions. — J Cosmet Dermatol, 2023. PMID 37381168.
- systematic review
Across treatments for androgenetic alopecia, low-level laser therapy, PRP and medical therapy each showed benefit over placebo, with medical therapy having the largest and most consistent evidence base.
The effectiveness of treatments for androgenetic alopecia: A systematic review and meta-analysis. — J Am Acad Dermatol, 2017. PMID 28396101.
Studies are selected for relevance and quality, not for agreement with the verdict; PubMed records are linked so the reader can check them.
Who it suits
Suits
Early to moderate thinning with miniaturised but living follicles; people willing to maintain treatment.
Not for
Scarring alopecia, fully bald areas, anyone expecting a one-off cure. Relocating hair does not stop the loss that made the transplant necessary.
Alternatives
The two reviewed treatments most often weighed against Hair thinning, on the same standard.
| Hair thinning | Finasteride and dutasteride for hair loss | Minoxidil | |
|---|---|---|---|
| Verdict | Promising | Established | Established |
| What it is | Non-surgical options for thinning hair: PRP injections of the patient's own concentrated platelets into the scalp, low-level laser or LED caps, scalp microneedling with or without topicals, and newer exosome applications. | Finasteride and dutasteride block the 5-alpha-reductase enzyme that converts testosterone to dihydrotestosterone (DHT), the hormone that miniaturises genetically sensitive follicles in male pattern hair loss. | Minoxidil was a blood-pressure medicine whose hair-growth side effect became a treatment. |
| Evidence base | 4 PubMed-indexed studies cited below, including systematic reviews. | 5 PubMed-indexed studies cited below, including systematic reviews, meta-analyses. | 5 PubMed-indexed studies cited below, including meta-analyses, randomised trials. |
| Suits | Early to moderate thinning with miniaturised but living follicles; people willing to maintain treatment. | Men with early to moderate pattern hair loss who want to keep what they have and regain some density, who accept indefinite treatment and the small risk of sexual side effects; often combined with minoxidil and considered before or alongside transplantation. | Pattern hair loss in men and women who will use it indefinitely; people who cannot tolerate topical application; combined with finasteride or dutasteride in men and with other measures in women, under a doctor. |
| In one line | Dr Sin Yong's H2LT and Luminescence protocols treat the follicular environment — a third route, separate from circulation and the androgen pathway. | The side-effect debate is loud and the trial numbers are small; the right conversation is a frank one with a doctor, not a thread. | It works while you take it and only then; the tablet is more convenient than the foam, not more magical. |
Risks
Scalp tenderness and swelling after injections; low risk with laser; unknowns with exosomes.
In Singapore
PRP is prepared and injected by doctors in Singapore clinics; laser caps are consumer or clinic devices. Prescription hair medicines are discussed with a doctor and not advertised here.
“Dr Sin Yong's H2LT and Luminescence protocols treat the follicular environment — a third route, separate from circulation and the androgen pathway.”
Vetted protocols on the same problem
Questions
Does PRP regrow hair?
How often is PRP repeated?
Laser cap or clinic treatment?
Cite this review
Aesthetics International (2026). Hair thinning: PRP, exosomes and laser: does it work? Evidence, risks and verdict. https://aesthetics-international.org/treatments/hair-prp-exosomes-laser/ (reviewed 1 October 2026).
Editorial, unpaid and independent of any manufacturer. Verdict: Promising. See what works and what doesn't across all 153 reviews. Spotted an error or a newer study? Suggest a correction — changes are logged on the corrections page. Terms are defined in the glossary.
Where this review is used
Have a question about this treatment?
Ask us — or ask to be matched with a practitioner in Singapore who follows evidence-based treatment. Whether it is right for you is decided at an in-person assessment, not by a review; sometimes the answer is a different treatment, or none.
WhatsApp +65 8023 7170Suggest a treatment to review
Physicians, manufacturers and readers can propose a treatment for review. Reviews are editorial and are not paid for.
[email protected]